Retention strategies are routinely communicated to potential trial participants but often differ from what was planned in the trial protocol: an analysis of adult participant information leaflets and their corresponding protocols
Background Retaining participants in randomised controlled trials (RCTs) is challenging and trial teams are often required to use strategies to ensure retention or improve it. Other than monetary incentives, there is no requirement to disclose the use of retention strategies to the participant. Addi...
Saved in:
Published in | Current controlled trials in cardiovascular medicine Vol. 25; no. 1; pp. 372 - 14 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
London
BioMed Central
10.06.2024
BioMed Central Ltd BMC |
Subjects | |
Online Access | Get full text |
ISSN | 1745-6215 1745-6215 |
DOI | 10.1186/s13063-024-08194-7 |
Cover
Abstract | Background
Retaining participants in randomised controlled trials (RCTs) is challenging and trial teams are often required to use strategies to ensure retention or improve it. Other than monetary incentives, there is no requirement to disclose the use of retention strategies to the participant. Additionally, not all retention strategies are developed at the planning stage, i.e. post-funding during protocol development, but some protocols include strategies for participant retention as retention is considered and planned for early in the trial planning stage. It is yet unknown if these plans are communicated in the corresponding participant information leaflets (PILs). The purpose of our study was to determine if PILs communicate plans to promote participant retention and, if so, are these outlined in the corresponding trial protocol.
Methods
Ninety-two adult PILs and their 90 corresponding protocols from Clinical Trial Units (CTUs) in the UK were analysed. Directed (deductive) content analysis was used to analyse the participant retention text from the PILs. Data were presented using a narrative summary and frequencies where appropriate.
Results
Plans to promote participant retention were communicated in 81.5% (
n
= 75/92) of PILs. Fifty-seven percent (
n
= 43/75) of PILs communicated plans to use “combined strategies” to promote participant retention. The most common individual retention strategy was telling the participants that data collection for the trial would be scheduled during routine care visits (16%;
n
= 12/75 PILs). The importance of retention and the impact that missing or deleted data (deleting data collected prior to withdrawal) has on the ability to answer the research question were explained in 6.5% (
n
= 6/92) and 5.4% (
n
= 5/92) of PILs respectively. Out of the 59 PILs and 58 matching protocols that both communicated plans to use strategies to promote participant retention, 18.6% (
n
= 11/59) communicated the same information, the remaining 81.4% (
n
= 48/59) of PILs either only partially communicated (45.8%;
n
= 27/59) the same information or did not communicate the same information (35.6%;
n
= 21/59) as the protocol with regard to the retention strategy(ies).
Conclusion
Retention strategies are frequently communicated to potential trial participants in PILs; however, the information provided often differs from the content in the corresponding protocol. Participant retention considerations are best done at the planning stage of the trial and we encourage trial teams to be consistent in the communication of these strategies in both the protocol and PIL. |
---|---|
AbstractList | Retaining participants in randomised controlled trials (RCTs) is challenging and trial teams are often required to use strategies to ensure retention or improve it. Other than monetary incentives, there is no requirement to disclose the use of retention strategies to the participant. Additionally, not all retention strategies are developed at the planning stage, i.e. post-funding during protocol development, but some protocols include strategies for participant retention as retention is considered and planned for early in the trial planning stage. It is yet unknown if these plans are communicated in the corresponding participant information leaflets (PILs). The purpose of our study was to determine if PILs communicate plans to promote participant retention and, if so, are these outlined in the corresponding trial protocol.BACKGROUNDRetaining participants in randomised controlled trials (RCTs) is challenging and trial teams are often required to use strategies to ensure retention or improve it. Other than monetary incentives, there is no requirement to disclose the use of retention strategies to the participant. Additionally, not all retention strategies are developed at the planning stage, i.e. post-funding during protocol development, but some protocols include strategies for participant retention as retention is considered and planned for early in the trial planning stage. It is yet unknown if these plans are communicated in the corresponding participant information leaflets (PILs). The purpose of our study was to determine if PILs communicate plans to promote participant retention and, if so, are these outlined in the corresponding trial protocol.Ninety-two adult PILs and their 90 corresponding protocols from Clinical Trial Units (CTUs) in the UK were analysed. Directed (deductive) content analysis was used to analyse the participant retention text from the PILs. Data were presented using a narrative summary and frequencies where appropriate.METHODSNinety-two adult PILs and their 90 corresponding protocols from Clinical Trial Units (CTUs) in the UK were analysed. Directed (deductive) content analysis was used to analyse the participant retention text from the PILs. Data were presented using a narrative summary and frequencies where appropriate.Plans to promote participant retention were communicated in 81.5% (n = 75/92) of PILs. Fifty-seven percent (n = 43/75) of PILs communicated plans to use "combined strategies" to promote participant retention. The most common individual retention strategy was telling the participants that data collection for the trial would be scheduled during routine care visits (16%; n = 12/75 PILs). The importance of retention and the impact that missing or deleted data (deleting data collected prior to withdrawal) has on the ability to answer the research question were explained in 6.5% (n = 6/92) and 5.4% (n = 5/92) of PILs respectively. Out of the 59 PILs and 58 matching protocols that both communicated plans to use strategies to promote participant retention, 18.6% (n = 11/59) communicated the same information, the remaining 81.4% (n = 48/59) of PILs either only partially communicated (45.8%; n = 27/59) the same information or did not communicate the same information (35.6%; n = 21/59) as the protocol with regard to the retention strategy(ies).RESULTSPlans to promote participant retention were communicated in 81.5% (n = 75/92) of PILs. Fifty-seven percent (n = 43/75) of PILs communicated plans to use "combined strategies" to promote participant retention. The most common individual retention strategy was telling the participants that data collection for the trial would be scheduled during routine care visits (16%; n = 12/75 PILs). The importance of retention and the impact that missing or deleted data (deleting data collected prior to withdrawal) has on the ability to answer the research question were explained in 6.5% (n = 6/92) and 5.4% (n = 5/92) of PILs respectively. Out of the 59 PILs and 58 matching protocols that both communicated plans to use strategies to promote participant retention, 18.6% (n = 11/59) communicated the same information, the remaining 81.4% (n = 48/59) of PILs either only partially communicated (45.8%; n = 27/59) the same information or did not communicate the same information (35.6%; n = 21/59) as the protocol with regard to the retention strategy(ies).Retention strategies are frequently communicated to potential trial participants in PILs; however, the information provided often differs from the content in the corresponding protocol. Participant retention considerations are best done at the planning stage of the trial and we encourage trial teams to be consistent in the communication of these strategies in both the protocol and PIL.CONCLUSIONRetention strategies are frequently communicated to potential trial participants in PILs; however, the information provided often differs from the content in the corresponding protocol. Participant retention considerations are best done at the planning stage of the trial and we encourage trial teams to be consistent in the communication of these strategies in both the protocol and PIL. Retaining participants in randomised controlled trials (RCTs) is challenging and trial teams are often required to use strategies to ensure retention or improve it. Other than monetary incentives, there is no requirement to disclose the use of retention strategies to the participant. Additionally, not all retention strategies are developed at the planning stage, i.e. post-funding during protocol development, but some protocols include strategies for participant retention as retention is considered and planned for early in the trial planning stage. It is yet unknown if these plans are communicated in the corresponding participant information leaflets (PILs). The purpose of our study was to determine if PILs communicate plans to promote participant retention and, if so, are these outlined in the corresponding trial protocol. Ninety-two adult PILs and their 90 corresponding protocols from Clinical Trial Units (CTUs) in the UK were analysed. Directed (deductive) content analysis was used to analyse the participant retention text from the PILs. Data were presented using a narrative summary and frequencies where appropriate. Plans to promote participant retention were communicated in 81.5% (n = 75/92) of PILs. Fifty-seven percent (n = 43/75) of PILs communicated plans to use "combined strategies" to promote participant retention. The most common individual retention strategy was telling the participants that data collection for the trial would be scheduled during routine care visits (16%; n = 12/75 PILs). The importance of retention and the impact that missing or deleted data (deleting data collected prior to withdrawal) has on the ability to answer the research question were explained in 6.5% (n = 6/92) and 5.4% (n = 5/92) of PILs respectively. Out of the 59 PILs and 58 matching protocols that both communicated plans to use strategies to promote participant retention, 18.6% (n = 11/59) communicated the same information, the remaining 81.4% (n = 48/59) of PILs either only partially communicated (45.8%; n = 27/59) the same information or did not communicate the same information (35.6%; n = 21/59) as the protocol with regard to the retention strategy(ies). Retention strategies are frequently communicated to potential trial participants in PILs; however, the information provided often differs from the content in the corresponding protocol. Participant retention considerations are best done at the planning stage of the trial and we encourage trial teams to be consistent in the communication of these strategies in both the protocol and PIL. Background Retaining participants in randomised controlled trials (RCTs) is challenging and trial teams are often required to use strategies to ensure retention or improve it. Other than monetary incentives, there is no requirement to disclose the use of retention strategies to the participant. Additionally, not all retention strategies are developed at the planning stage, i.e. post-funding during protocol development, but some protocols include strategies for participant retention as retention is considered and planned for early in the trial planning stage. It is yet unknown if these plans are communicated in the corresponding participant information leaflets (PILs). The purpose of our study was to determine if PILs communicate plans to promote participant retention and, if so, are these outlined in the corresponding trial protocol. Methods Ninety-two adult PILs and their 90 corresponding protocols from Clinical Trial Units (CTUs) in the UK were analysed. Directed (deductive) content analysis was used to analyse the participant retention text from the PILs. Data were presented using a narrative summary and frequencies where appropriate. Results Plans to promote participant retention were communicated in 81.5% (n = 75/92) of PILs. Fifty-seven percent (n = 43/75) of PILs communicated plans to use "combined strategies" to promote participant retention. The most common individual retention strategy was telling the participants that data collection for the trial would be scheduled during routine care visits (16%; n = 12/75 PILs). The importance of retention and the impact that missing or deleted data (deleting data collected prior to withdrawal) has on the ability to answer the research question were explained in 6.5% (n = 6/92) and 5.4% (n = 5/92) of PILs respectively. Out of the 59 PILs and 58 matching protocols that both communicated plans to use strategies to promote participant retention, 18.6% (n = 11/59) communicated the same information, the remaining 81.4% (n = 48/59) of PILs either only partially communicated (45.8%; n = 27/59) the same information or did not communicate the same information (35.6%; n = 21/59) as the protocol with regard to the retention strategy(ies). Conclusion Retention strategies are frequently communicated to potential trial participants in PILs; however, the information provided often differs from the content in the corresponding protocol. Participant retention considerations are best done at the planning stage of the trial and we encourage trial teams to be consistent in the communication of these strategies in both the protocol and PIL. Keywords: Retention, Retention strategy, Reporting, Communication, Participant information leaflet, Patient information leaflet, Informed consent Retaining participants in randomised controlled trials (RCTs) is challenging and trial teams are often required to use strategies to ensure retention or improve it. Other than monetary incentives, there is no requirement to disclose the use of retention strategies to the participant. Additionally, not all retention strategies are developed at the planning stage, i.e. post-funding during protocol development, but some protocols include strategies for participant retention as retention is considered and planned for early in the trial planning stage. It is yet unknown if these plans are communicated in the corresponding participant information leaflets (PILs). The purpose of our study was to determine if PILs communicate plans to promote participant retention and, if so, are these outlined in the corresponding trial protocol. Ninety-two adult PILs and their 90 corresponding protocols from Clinical Trial Units (CTUs) in the UK were analysed. Directed (deductive) content analysis was used to analyse the participant retention text from the PILs. Data were presented using a narrative summary and frequencies where appropriate. Plans to promote participant retention were communicated in 81.5% (n = 75/92) of PILs. Fifty-seven percent (n = 43/75) of PILs communicated plans to use "combined strategies" to promote participant retention. The most common individual retention strategy was telling the participants that data collection for the trial would be scheduled during routine care visits (16%; n = 12/75 PILs). The importance of retention and the impact that missing or deleted data (deleting data collected prior to withdrawal) has on the ability to answer the research question were explained in 6.5% (n = 6/92) and 5.4% (n = 5/92) of PILs respectively. Out of the 59 PILs and 58 matching protocols that both communicated plans to use strategies to promote participant retention, 18.6% (n = 11/59) communicated the same information, the remaining 81.4% (n = 48/59) of PILs either only partially communicated (45.8%; n = 27/59) the same information or did not communicate the same information (35.6%; n = 21/59) as the protocol with regard to the retention strategy(ies). Retention strategies are frequently communicated to potential trial participants in PILs; however, the information provided often differs from the content in the corresponding protocol. Participant retention considerations are best done at the planning stage of the trial and we encourage trial teams to be consistent in the communication of these strategies in both the protocol and PIL. BackgroundRetaining participants in randomised controlled trials (RCTs) is challenging and trial teams are often required to use strategies to ensure retention or improve it. Other than monetary incentives, there is no requirement to disclose the use of retention strategies to the participant. Additionally, not all retention strategies are developed at the planning stage, i.e. post-funding during protocol development, but some protocols include strategies for participant retention as retention is considered and planned for early in the trial planning stage. It is yet unknown if these plans are communicated in the corresponding participant information leaflets (PILs). The purpose of our study was to determine if PILs communicate plans to promote participant retention and, if so, are these outlined in the corresponding trial protocol.MethodsNinety-two adult PILs and their 90 corresponding protocols from Clinical Trial Units (CTUs) in the UK were analysed. Directed (deductive) content analysis was used to analyse the participant retention text from the PILs. Data were presented using a narrative summary and frequencies where appropriate.ResultsPlans to promote participant retention were communicated in 81.5% (n = 75/92) of PILs. Fifty-seven percent (n = 43/75) of PILs communicated plans to use “combined strategies” to promote participant retention. The most common individual retention strategy was telling the participants that data collection for the trial would be scheduled during routine care visits (16%; n = 12/75 PILs). The importance of retention and the impact that missing or deleted data (deleting data collected prior to withdrawal) has on the ability to answer the research question were explained in 6.5% (n = 6/92) and 5.4% (n = 5/92) of PILs respectively. Out of the 59 PILs and 58 matching protocols that both communicated plans to use strategies to promote participant retention, 18.6% (n = 11/59) communicated the same information, the remaining 81.4% (n = 48/59) of PILs either only partially communicated (45.8%; n = 27/59) the same information or did not communicate the same information (35.6%; n = 21/59) as the protocol with regard to the retention strategy(ies).ConclusionRetention strategies are frequently communicated to potential trial participants in PILs; however, the information provided often differs from the content in the corresponding protocol. Participant retention considerations are best done at the planning stage of the trial and we encourage trial teams to be consistent in the communication of these strategies in both the protocol and PIL. Abstract Background Retaining participants in randomised controlled trials (RCTs) is challenging and trial teams are often required to use strategies to ensure retention or improve it. Other than monetary incentives, there is no requirement to disclose the use of retention strategies to the participant. Additionally, not all retention strategies are developed at the planning stage, i.e. post-funding during protocol development, but some protocols include strategies for participant retention as retention is considered and planned for early in the trial planning stage. It is yet unknown if these plans are communicated in the corresponding participant information leaflets (PILs). The purpose of our study was to determine if PILs communicate plans to promote participant retention and, if so, are these outlined in the corresponding trial protocol. Methods Ninety-two adult PILs and their 90 corresponding protocols from Clinical Trial Units (CTUs) in the UK were analysed. Directed (deductive) content analysis was used to analyse the participant retention text from the PILs. Data were presented using a narrative summary and frequencies where appropriate. Results Plans to promote participant retention were communicated in 81.5% (n = 75/92) of PILs. Fifty-seven percent (n = 43/75) of PILs communicated plans to use “combined strategies” to promote participant retention. The most common individual retention strategy was telling the participants that data collection for the trial would be scheduled during routine care visits (16%; n = 12/75 PILs). The importance of retention and the impact that missing or deleted data (deleting data collected prior to withdrawal) has on the ability to answer the research question were explained in 6.5% (n = 6/92) and 5.4% (n = 5/92) of PILs respectively. Out of the 59 PILs and 58 matching protocols that both communicated plans to use strategies to promote participant retention, 18.6% (n = 11/59) communicated the same information, the remaining 81.4% (n = 48/59) of PILs either only partially communicated (45.8%; n = 27/59) the same information or did not communicate the same information (35.6%; n = 21/59) as the protocol with regard to the retention strategy(ies). Conclusion Retention strategies are frequently communicated to potential trial participants in PILs; however, the information provided often differs from the content in the corresponding protocol. Participant retention considerations are best done at the planning stage of the trial and we encourage trial teams to be consistent in the communication of these strategies in both the protocol and PIL. Background Retaining participants in randomised controlled trials (RCTs) is challenging and trial teams are often required to use strategies to ensure retention or improve it. Other than monetary incentives, there is no requirement to disclose the use of retention strategies to the participant. Additionally, not all retention strategies are developed at the planning stage, i.e. post-funding during protocol development, but some protocols include strategies for participant retention as retention is considered and planned for early in the trial planning stage. It is yet unknown if these plans are communicated in the corresponding participant information leaflets (PILs). The purpose of our study was to determine if PILs communicate plans to promote participant retention and, if so, are these outlined in the corresponding trial protocol. Methods Ninety-two adult PILs and their 90 corresponding protocols from Clinical Trial Units (CTUs) in the UK were analysed. Directed (deductive) content analysis was used to analyse the participant retention text from the PILs. Data were presented using a narrative summary and frequencies where appropriate. Results Plans to promote participant retention were communicated in 81.5% ( n = 75/92) of PILs. Fifty-seven percent ( n = 43/75) of PILs communicated plans to use “combined strategies” to promote participant retention. The most common individual retention strategy was telling the participants that data collection for the trial would be scheduled during routine care visits (16%; n = 12/75 PILs). The importance of retention and the impact that missing or deleted data (deleting data collected prior to withdrawal) has on the ability to answer the research question were explained in 6.5% ( n = 6/92) and 5.4% ( n = 5/92) of PILs respectively. Out of the 59 PILs and 58 matching protocols that both communicated plans to use strategies to promote participant retention, 18.6% ( n = 11/59) communicated the same information, the remaining 81.4% ( n = 48/59) of PILs either only partially communicated (45.8%; n = 27/59) the same information or did not communicate the same information (35.6%; n = 21/59) as the protocol with regard to the retention strategy(ies). Conclusion Retention strategies are frequently communicated to potential trial participants in PILs; however, the information provided often differs from the content in the corresponding protocol. Participant retention considerations are best done at the planning stage of the trial and we encourage trial teams to be consistent in the communication of these strategies in both the protocol and PIL. |
ArticleNumber | 372 |
Audience | Academic |
Author | Shiely, Frances Gillies, Katie Murphy, Ellen |
Author_xml | – sequence: 1 givenname: Ellen orcidid: 0000-0001-7874-4331 surname: Murphy fullname: Murphy, Ellen email: ellen.murphy@ucc.ie organization: Health Research Board-Trials Methodology Research Network (HRB-TMRN), Trials Research and Methodologies Unit (TRAMS), Health Research Board Clinical Research Facility University College Cork – sequence: 2 givenname: Katie surname: Gillies fullname: Gillies, Katie organization: Health Services Research Unit, University of Aberdeen – sequence: 3 givenname: Frances surname: Shiely fullname: Shiely, Frances organization: Health Research Board-Trials Methodology Research Network (HRB-TMRN), Trials Research and Methodologies Unit (TRAMS), Health Research Board Clinical Research Facility University College Cork, School of Public Health, University College Cork |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38858790$$D View this record in MEDLINE/PubMed |
BookMark | eNp9k9tq3DAQhk1JaQ7tC_SiCHrTG6eSZUl2b0oIPQQChdJeC1kebxRsyZXkhDxw36Ozu8lmU0qxsYX0_99opJnj4sAHD0XxmtFTxhr5PjFOJS9pVZe0YW1dqmfFEVO1KGXFxMHe-LA4Tuma0pq3vH5RHPKmEY1q6VHx-ztk8NkFT1KOJsPKQSImAolhyc7DeEdsmKbFO4urPcmBzGFjMSPJcf2dTczOutn4nEi3ZBIGFJDeDQNEMsQwkdsrk8mtSWQejfeIcZ7kK3gAxJCDDeMHYjy-ZrxLLiGFmH4Z8z4ffUOIk9lseAQzjIAxje_XNBdxqzFCmoPvnV_tuOll8XwwY4JX9_-T4ufnTz_Ov5aX375cnJ9dllaINpe96HtuDFQMWtqAoJ1iEqp64JUSVrXKCsWtlD2TTV0JYTkODK0H2tiqY5afFBdbbh_MtZ6jm0y808E4vZkIcaU3uYygZV1XtO6gkqyreQMN58p0EgxjppGCIuvjljUv3QS9xSOPZnwCfbri3ZVehRvNGJNcyQoJ7-4JMfxaIGU9uWRhxCuAsCSN1SNV07ZYRCfF27-k12GJeBNbFRMKS-lRtTKYwfoqMLBdQ_UZnk7V0pauw57-Q4VPD5OzWMKDw_knhjf7me5SfKhSFFRbgY0hpQjDTsKoXreC3raCxlbQm1bQCk18a0oo9iuIjyn9x_UHtNUQmg |
Cites_doi | 10.1186/s13063-023-07775-2 10.7326/0003-4819-158-3-201302050-00583 10.1186/1471-2288-14-118 10.1136/bmj.e2809 10.1136/bmjmed-2022-000217 10.1186/s13063-022-06223-x 10.1136/bmj.k4738 10.1136/bmjopen-2014-005734 10.1177/1740774515597702 10.1016/j.jclinepi.2020.03.011 10.1001/jamasurg.2018.4318 10.1136/bmjopen-2018-023303 10.1136/bmjopen-2020-048128 10.1186/s13063-019-3687-7 10.1186/s13063-017-2132-z 10.1177/1744987117741667 10.1016/j.jclinepi.2013.10.019 10.1136/bmj.e7586 10.1186/s12874-022-01708-4 10.1186/s13063-019-3704-x 10.1177/1049732305276687 10.1177/26320843221147838 10.1186/s13063-018-2467-0 10.1186/s13063-018-2535-5 10.1371/journal.pone.0204886 10.1111/j.1365-2648.2007.04569.x 10.1186/s13063-020-04591-w 10.1136/jme.2010.041871 10.1136/adc.2007.127316 10.1136/bmjopen-2016-015276 10.1016/j.jclinepi.2021.03.007 10.1186/1745-6215-15-399 10.1136/bmjopen-2018-021959 10.1016/S0140-6736(13)62297-7 |
ContentType | Journal Article |
Copyright | The Author(s) 2024 2024. The Author(s). COPYRIGHT 2024 BioMed Central Ltd. The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: The Author(s) 2024 – notice: 2024. The Author(s). – notice: COPYRIGHT 2024 BioMed Central Ltd. – notice: The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7RV 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. KB0 M0S M1P NAPCQ PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.1186/s13063-024-08194-7 |
DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Nursing & Allied Health Database Health & Medical Collection (ProQuest) ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials - QC ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ProQuest Health & Medical Collection Medical Database Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 5 dbid: BENPR name: ProQuest url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1745-6215 |
EndPage | 14 |
ExternalDocumentID | oai_doaj_org_article_644204be261b438e8337ab6ea11a8650 PMC11163762 A797290902 38858790 10_1186_s13063_024_08194_7 |
Genre | Journal Article |
GeographicLocations | United Kingdom United Kingdom--UK |
GeographicLocations_xml | – name: United Kingdom – name: United Kingdom--UK |
GrantInformation_xml | – fundername: Health Research Board – Trials Methodology Research Network grantid: HRB-TMRN-2021-001 – fundername: Health Research Board - Trials Methodology Research Network grantid: HRB-TMRN-2021-001 |
GroupedDBID | --- 0R~ 123 2-G 29Q 2WC 53G 5VS 6PF 7RV 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL ABDBF ABUWG ACGFO ACGFS ACUHS ADBBV ADRAZ ADUKV AEGXH AENEX AFKRA AFPKN AHBYD AHYZX AIAGR ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC C6C CCPQU CS3 DIK DU5 E3Z EBD EBLON EBS EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR INH INR ITC KQ8 M1P M48 M~E NAPCQ O5R O5S OVT PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PSQYO PUEGO RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 TUS U2A UKHRP WOQ WOW ~8M AAYXX ALIPV CITATION CGR CUY CVF ECM EIF NPM PMFND 3V. 5GY 7XB 8FK AHMBA AZQEC DWQXO K9. PKEHL PQEST PQQKQ PQUKI PRINS XSB 7X8 5PM |
ID | FETCH-LOGICAL-c559t-d5dd3aae21e908e50b716e24f3275c797c573c66d1684255c3168a04f08c2b1c3 |
IEDL.DBID | M48 |
ISSN | 1745-6215 |
IngestDate | Wed Aug 27 01:26:39 EDT 2025 Thu Aug 21 18:33:09 EDT 2025 Thu Sep 04 21:38:48 EDT 2025 Sat Jul 26 03:28:50 EDT 2025 Tue Jun 17 22:08:54 EDT 2025 Tue Jun 10 21:13:39 EDT 2025 Mon Jul 21 06:02:10 EDT 2025 Tue Jul 01 04:01:24 EDT 2025 Sat Sep 06 07:31:52 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Retention strategy Informed consent Participant information leaflet Retention Reporting Communication Patient information leaflet |
Language | English |
License | 2024. The Author(s). Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c559t-d5dd3aae21e908e50b716e24f3275c797c573c66d1684255c3168a04f08c2b1c3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0001-7874-4331 |
OpenAccessLink | https://link.springer.com/10.1186/s13063-024-08194-7 |
PMID | 38858790 |
PQID | 3066157745 |
PQPubID | 44365 |
PageCount | 14 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_644204be261b438e8337ab6ea11a8650 pubmedcentral_primary_oai_pubmedcentral_nih_gov_11163762 proquest_miscellaneous_3066789906 proquest_journals_3066157745 gale_infotracmisc_A797290902 gale_infotracacademiconefile_A797290902 pubmed_primary_38858790 crossref_primary_10_1186_s13063_024_08194_7 springer_journals_10_1186_s13063_024_08194_7 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2024-06-10 |
PublicationDateYYYYMMDD | 2024-06-10 |
PublicationDate_xml | – month: 06 year: 2024 text: 2024-06-10 day: 10 |
PublicationDecade | 2020 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationTitle | Current controlled trials in cardiovascular medicine |
PublicationTitleAbbrev | Trials |
PublicationTitleAlternate | Trials |
PublicationYear | 2024 |
Publisher | BioMed Central BioMed Central Ltd BMC |
Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd – name: BMC |
References | S Elo (8194_CR29) 2008; 62 EE Antoniou (8194_CR40) 2011; 37 SJ Walters (8194_CR2) 2017; 7 A Assarroudi (8194_CR31) 2018; 23 K Innes (8194_CR39) 2018; 8 A Daykin (8194_CR25) 2018; 19 E Murphy (8194_CR26) 2023; 24 NK Kibiswa (8194_CR32) 2019; 24 D Brunsdon (8194_CR1) 2019; 20 M Walsh (8194_CR6) 2014; 67 MS Fewtrell (8194_CR8) 2008; 93 ML Bell (8194_CR9) 2014; 14 JC Crocker (8194_CR44) 2018; 363 K Gillies (8194_CR3) 2021; 3 A Kearney (8194_CR14) 2018; 13 8194_CR22 ZC Skea (8194_CR19) 2019; 9 8194_CR27 8194_CR24 H-F Hsieh (8194_CR30) 2005; 15 S Treweek (8194_CR42) 2018; 19 A Kearney (8194_CR13) 2017; 18 L Lawrie (8194_CR20) 2021; 11 C Weijer (8194_CR23) 1997; 156 CJ Tignanelli (8194_CR7) 2019; 154 IH Guideline (8194_CR21) 2015; 2 K Gillies (8194_CR11) 2019; 20 PeRSEVERE collaborative group (8194_CR41) 2023 A-W Chan (8194_CR28) 2013; 158 EA Akl (8194_CR5) 2012; 344 JS Lees (8194_CR43) 2022; 1 8194_CR34 8194_CR33 E Murphy (8194_CR36) 2022; 23 8194_CR37 M Walsh (8194_CR4) 2015; 12 P Bower (8194_CR12) 2014; 15 P Tunji-Ajayi (8194_CR15) 2020; 123 Clinical Research Ethics Committee of the Cork Teaching Hospitals (CREC) (8194_CR35) 2015 N Kirby (8194_CR38) 2020; 21 RA-S Salman (8194_CR10) 2014; 383 R Newlands (8194_CR17) 2021; 137 K Gillies (8194_CR16) 2014; 4 T Coffey (8194_CR18) 2022; 22 |
References_xml | – volume: 24 start-page: 784 issue: 1 year: 2023 ident: 8194_CR26 publication-title: Trials. doi: 10.1186/s13063-023-07775-2 – volume: 158 start-page: 200 issue: 3 year: 2013 ident: 8194_CR28 publication-title: Ann Intern Med. doi: 10.7326/0003-4819-158-3-201302050-00583 – volume: 14 start-page: 1 issue: 1 year: 2014 ident: 8194_CR9 publication-title: BMC Med Res Methodol doi: 10.1186/1471-2288-14-118 – volume-title: eRSEVERE: PRincipleS for handling end of participation EVEnts in clinical trials REsearch. Principles and explanation – September 2023 year: 2023 ident: 8194_CR41 – volume: 156 start-page: 1153 issue: 8 year: 1997 ident: 8194_CR23 publication-title: Research ethics. CMAJ. – volume: 344 start-page: e2809 year: 2012 ident: 8194_CR5 publication-title: BMJ doi: 10.1136/bmj.e2809 – ident: 8194_CR22 – volume: 1 start-page: e000217 issue: 1 year: 2022 ident: 8194_CR43 publication-title: BMJ Med doi: 10.1136/bmjmed-2022-000217 – ident: 8194_CR24 – volume: 23 start-page: 396 issue: 1 year: 2022 ident: 8194_CR36 publication-title: Trials. doi: 10.1186/s13063-022-06223-x – volume: 24 start-page: 2059 issue: 8 year: 2019 ident: 8194_CR32 publication-title: Qual Rep – volume: 363 start-page: k4738 year: 2018 ident: 8194_CR44 publication-title: BMJ. doi: 10.1136/bmj.k4738 – volume: 4 start-page: e005734 issue: 8 year: 2014 ident: 8194_CR16 publication-title: BMJ open. doi: 10.1136/bmjopen-2014-005734 – volume: 12 start-page: 537 issue: 5 year: 2015 ident: 8194_CR4 publication-title: Clin Trials doi: 10.1177/1740774515597702 – volume: 123 start-page: 49 year: 2020 ident: 8194_CR15 publication-title: J Clin Epidemiol. doi: 10.1016/j.jclinepi.2020.03.011 – volume: 154 start-page: 74 issue: 1 year: 2019 ident: 8194_CR7 publication-title: JAMA Surg doi: 10.1001/jamasurg.2018.4318 – volume: 8 start-page: e023303 issue: 9 year: 2018 ident: 8194_CR39 publication-title: BMJ open. doi: 10.1136/bmjopen-2018-023303 – volume-title: Policies and Procedures Manual Including Application Forms year: 2015 ident: 8194_CR35 – volume: 11 start-page: e048128 issue: 4 year: 2021 ident: 8194_CR20 publication-title: BMJ open. doi: 10.1136/bmjopen-2020-048128 – ident: 8194_CR33 – volume: 20 start-page: 1 issue: 1 year: 2019 ident: 8194_CR1 publication-title: Trials. doi: 10.1186/s13063-019-3687-7 – volume: 18 start-page: 406 issue: 1 year: 2017 ident: 8194_CR13 publication-title: Trials. doi: 10.1186/s13063-017-2132-z – volume: 3 start-page: MR000032 issue: 3 year: 2021 ident: 8194_CR3 publication-title: Cochrane Database of Syst Rev – volume: 23 start-page: 42 issue: 1 year: 2018 ident: 8194_CR31 publication-title: J Res Nurs. doi: 10.1177/1744987117741667 – volume: 67 start-page: 622 issue: 6 year: 2014 ident: 8194_CR6 publication-title: J Clin Epidemiol doi: 10.1016/j.jclinepi.2013.10.019 – ident: 8194_CR27 doi: 10.1136/bmj.e7586 – volume: 22 start-page: 1 issue: 1 year: 2022 ident: 8194_CR18 publication-title: BMC Med Res Methodol doi: 10.1186/s12874-022-01708-4 – volume: 20 start-page: 1 issue: 1 year: 2019 ident: 8194_CR11 publication-title: Trials. doi: 10.1186/s13063-019-3704-x – volume: 15 start-page: 1277 issue: 9 year: 2005 ident: 8194_CR30 publication-title: Qual Health Res. doi: 10.1177/1049732305276687 – ident: 8194_CR37 doi: 10.1177/26320843221147838 – volume: 19 start-page: 76 issue: 1 year: 2018 ident: 8194_CR25 publication-title: Trials. doi: 10.1186/s13063-018-2467-0 – volume: 19 start-page: 1 issue: 1 year: 2018 ident: 8194_CR42 publication-title: Trials. doi: 10.1186/s13063-018-2535-5 – volume: 13 start-page: e0204886 issue: 10 year: 2018 ident: 8194_CR14 publication-title: PLoS One. doi: 10.1371/journal.pone.0204886 – volume: 62 start-page: 107 issue: 1 year: 2008 ident: 8194_CR29 publication-title: J Adv Nurs. doi: 10.1111/j.1365-2648.2007.04569.x – volume: 21 start-page: 1 issue: 1 year: 2020 ident: 8194_CR38 publication-title: Trials. doi: 10.1186/s13063-020-04591-w – volume: 37 start-page: 557 issue: 9 year: 2011 ident: 8194_CR40 publication-title: J Med Ethics. doi: 10.1136/jme.2010.041871 – volume: 93 start-page: 458 issue: 6 year: 2008 ident: 8194_CR8 publication-title: Arch Dis Child doi: 10.1136/adc.2007.127316 – volume: 2 start-page: 1 year: 2015 ident: 8194_CR21 publication-title: Current Step. – volume: 7 start-page: e015276 issue: 3 year: 2017 ident: 8194_CR2 publication-title: BMJ open. doi: 10.1136/bmjopen-2016-015276 – volume: 137 start-page: 1 year: 2021 ident: 8194_CR17 publication-title: J Clin Epidemiol. doi: 10.1016/j.jclinepi.2021.03.007 – ident: 8194_CR34 – volume: 15 start-page: 399 issue: 1 year: 2014 ident: 8194_CR12 publication-title: Trials. doi: 10.1186/1745-6215-15-399 – volume: 9 start-page: e021959 issue: 6 year: 2019 ident: 8194_CR19 publication-title: BMJ Open. doi: 10.1136/bmjopen-2018-021959 – volume: 383 start-page: 176 issue: 9912 year: 2014 ident: 8194_CR10 publication-title: Lancet doi: 10.1016/S0140-6736(13)62297-7 |
SSID | ssj0043934 ssj0017864 |
Score | 2.3666325 |
Snippet | Background
Retaining participants in randomised controlled trials (RCTs) is challenging and trial teams are often required to use strategies to ensure... Retaining participants in randomised controlled trials (RCTs) is challenging and trial teams are often required to use strategies to ensure retention or... Background Retaining participants in randomised controlled trials (RCTs) is challenging and trial teams are often required to use strategies to ensure... BackgroundRetaining participants in randomised controlled trials (RCTs) is challenging and trial teams are often required to use strategies to ensure retention... Abstract Background Retaining participants in randomised controlled trials (RCTs) is challenging and trial teams are often required to use strategies to ensure... |
SourceID | doaj pubmedcentral proquest gale pubmed crossref springer |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 372 |
SubjectTerms | Adult Adults Analysis Biomedicine Clinical Trial Protocols as Topic Clinical trials Communication Health Knowledge, Attitudes, Practice Health Sciences Human subjects Humans Information Informed consent Medicine Medicine & Public Health Participant information leaflet Patient Dropouts Patient education Patient Education as Topic - methods Patient information leaflet Patient Selection Randomized Controlled Trials as Topic - methods Reporting Research Design Research Subjects - psychology Retention Retention strategy Statistics for Life Sciences United Kingdom |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Ni9UwEA-yB_Eiftt1lREED1q2zVdTb6u4LMJ6EBf2FtIkj11Y0sdrH4t_sP-Hk6R9blfEi_BOTTpvkv6SmWGS3xDyZlXTqltZjmFJq0puGS1bdLNLJmzrPFWiSzUjT7_KkzP-5Vyc3yj1Fc-EZXrgPHGHaK9pxTuPnn7HmfKKscZ00pu6NkrmaL1qqzmYynswWlnG5ysySh4OuFOnfCUvownkZbMwQ4mt_889-YZRun1g8lbWNBmj4wfk_uRFwlHW_iG548Mjcvd0ypM_Jj-_RV84zjkM40wGAWbjYdMj0oK_-gF2dzXEOxh7WPfpFRSbKnnA2kwnrsM4QLcdATdsHyBXVIF4LQWuL8wI12aAdSx9hGIuA6BDOQvY9GOPOPsAJuAvk5-gFEicHzflw0TfmhS-8rGgMP6nCQ5SHgNVjSVE1n26gbOTOzwhZ8efv386KaeCDqXFwGUsnXCOGeNp7dtKeVF1GK15yleMNsI2bWNFw6yUrk7ZQWFjVS1T8VWlLO1qy56SvdAH_5yAU9wJ6tCZYYa3kdZw5ZT1FRpbJY0wBXk3f1-9zrwdOsU7SuqMBo1o0AkNuinIxwiBXc_IuZ0eIBL1hET9LyQW5G0EkI5Thp_WmumCAyocObb0EQ6QtvEcbEEOFj1xRdtl8wxBPe0og0aV0flEZ10U5PWuOb4ZT8kF329znwYD6EoW5FlG7G5ITCmhmha1VAssL8a8bAmXF4lvHM2hRDuEer2fYf9br79P6v7_mNQX5B5Ny1aiw3BA9sbN1r9EN3DsXqUV_wt7GFxn priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection (ProQuest) dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9UwFA86QXwRv61OiSD4oGVtPprUF5niGMJ8EAf3LaRJrhuMtN72MvYH7__wJE27daJwn5r03JPkl_PRk5yD0Nt1SYpmbRi4JbXMmaEkr8HMzik3tXVE8ibWjDz6Xh0es28rvkof3Pp0rHKSiVFQ29aEb-R7YNqC8gVjhX_qfuehalSIrqYSGrfRnZi6DPAsVrPDVQpZsemijKz2epDXMWrJ8qAIWS4Wyijm7P9bMl9TTTePTd6InUaVdPAA3U-2JN4fF_8huuX8I3T3KEXLH6PLH8EiDjOP-2FKCYH1xuFNC3jz7uwCm_mCiLN4aHHXxleAbKzngTudzl37ocfNdsAgtp3HY10VHC6n4PMTPeBz3eMuFEACMqceg1k5Edi0Qwto-4i1h9-YAgWo4Jj54zp9nJK4RobPXCgrDP-pvcUxmgGshkIiXRvv4cx0-yfo-ODrzy-HeSrrkBtwX4bccmup1o6Uri6k40UDPpsjbE2J4EbUwnBBTVXZMsYIuQm1tXTB1oU0pCkNfYp2fOvdc4StZJYTCyYN1awOyQ3XVhpXgMqVleY6Q--n9VXdmL1DRa9HVmpEgwI0qIgGJTL0OUBg7hkyb8cH7eaXShtZgf1ICtY48DwbRqWTlArdVE6XpZZg7mboXQCQClMGS2t0uuYADIdMW2ofBkjqcBo2Q7uLnrCvzbJ5gqBKcqVXV7sgQ2_m5vBmOCvnXbsd-whwo4sqQ89GxM5DolJyKWrgUi6wvBjzssWfnsSs46AUK9BGwNeHCfZXfP17Ul_8fxgv0T0SN2QFBsEu2hk2W_cKzLyheR338h-o3VUS priority: 102 providerName: ProQuest – databaseName: SpringerLink Journals (ICM) dbid: U2A link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlR1Ni9UwMOgK4kX83q6rjCB40GKbjzb19hSXRVgP4oO9hTRJ3YUlfbz2sfiD9384ST_crnoQ3qlJ5k2S-WQyM4S8bnKa1Y3h6JZUMuWG0bRCMztlwlTWUSnq2DPy5GtxvOZfTsXpmBTWTa_dp5BklNSRrWXxvkNpG2OOPA1qjKflbXJHoO8e2HFNV5P8RQ3L-JQe89d1CxUUK_X_KY-vKaSbjyVvREyjIjp6QO6PFiSshit_SG45_4jcPRlj5I_J1bdgB4fzhq6fCkGA3jrYtkhl3l38BDOnhTgLfQubNi5BsLGLB2z0-Nra9x3Uux5QWDsPQzcVCCkpcHmme7jUHWxC2yMEc-4BjckJwLbtW6SxD6A9_obCJwgFYr2P6_BhLN0aEb5woZkw_qf2FmIMA1EN7UM2bcy-meF2T8j66PP3T8fp2MwhNei09KkV1jKtHc1dlUknsho9NUd5w2gpTFmVRpTMFIXNY2RQmNBRS2e8yaShdW7YU7LnW-_2CVjJraAWDRmmeRVKGjZWGpehopWFFjohb6f7VZuhZoeKvo4s1EANCqlBRWpQZUI-BhKYZ4Z62_FDu_2hRvZVaDXSjNcO_c2aM-kkY6WuC6fzXEs0chPyJhCQCkeGV2v0mNyACIf6WmqFG6RVeAObkMPFTORmsxyeSFCN0qRTiDIanmioi4S8mofDyvBCzrt2N8wp0XnOioQ8Gyh23hKTUsiyQizlgpYXe16O-POzWGscVWGBOgjxejeR_W-8_n2oB_83_Tm5RyODFmgWHJK9frtzL9DY6-uXkbd_AVGIUgY priority: 102 providerName: Springer Nature |
Title | Retention strategies are routinely communicated to potential trial participants but often differ from what was planned in the trial protocol: an analysis of adult participant information leaflets and their corresponding protocols |
URI | https://link.springer.com/article/10.1186/s13063-024-08194-7 https://www.ncbi.nlm.nih.gov/pubmed/38858790 https://www.proquest.com/docview/3066157745 https://www.proquest.com/docview/3066789906 https://pubmed.ncbi.nlm.nih.gov/PMC11163762 https://doaj.org/article/644204be261b438e8337ab6ea11a8650 |
Volume | 25 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1ta9swEBZ9gdIvY-_11gUNBvuwebP1ZnkwRlralUDK6BbINyHLyloIdmY7dP3B-x87yXaWdC0EByzpcpKe091F0h1Cb2YxibKZYeCWpDJkhpIwBTM7pNykuSWSZz5n5PhcnE3YaMqnW6hPd9QNYH2na-fySU2q-Yffv26-gMB_9gIvxcca1mG_G8lCp-BYmGyjXdBMwjljY7baVQDdS1l_cebOdvtoj0rJZeKW6DU95cP5_79or2mt2ycqb22rem11-hA96MxMPGxx8Qht2eIx2ht3G-lP0J8LZyy7ScF100eLwLqyuCoBioWd32Czujtic9yUeFH6JkDWp_rAC90dyS6aGmfLBsOKbgvcplzB7t4Kvr7UDb7WNV643EhA5qrAYHH2BKqyKQGIn7Au4NNGRwEq2AcFWaePu_iunuG5dRmH4Td1kWO_0QGsuhwji9Jf0VnRrZ-iyenJj-OzsMv4EBrwbJow53lOtbYktmkkLY8ycOcsYTNKEm6SNDE8oUaIPPbbh9y4tFs6YrNIGpLFhj5DO0VZ2AOEc8lyTnKwdqhmqYt7OMulsRFoYyk01wF618-vWrSBPZR3iKRQLTAUAEN5YKgkQEcOAquaLii3f1FWP1Un4wpMSxKxzIJTmjEqraQ00ZmwOo61BEs4QG8dgJQbMphao7sbEMCwC8KlhtBBkrqDsgE63KgJIm82i3sIql5iFLAM1ilY8zxAr1fFrqU7RlfYctnWScDDjkSAnreIXXWpB36A5AaWN_q8WVJcXfqA5KAvBSgq4Ot9D_t_fN0_qC_u5eEl2ideLAWYCYdop6mW9hUYf002QNvJNBmg3eFw9H0E30cn598u4O2xOB74P1Tg-XUaD7zkw3NChn8BtkJf6g |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELbKVgIuiDcpBYwE4gBRE8dOHCSEWmi1pd0VqlqpN-PY3rZSlYRNVqv-Kf4V_4Ox82hTBLdKe1o7s-P48zx2PDMIvZmFJMhmioJbknKfqoj4KZjZfsRUqg3hLHM9IyfTeHxEvx2z4xX0q8uFsdcqO5noBLUulP2PfANMW1C-YKywz-VP33aNstHVroVGA4s9c7EEl636tPsV9vctITvbh1_GfttVwFdgPde-ZlpHUhoSmjTghgUZuAyG0FlEEqaSNFEsiVQc69CFqJiyrZ1kQGcBVyQLVQR0b6FVajNaR2h1a3v6_aCPWyQ8pl1qDo83KtAQLk5Kfat6qZ8M1J_rEvC3LriiDK9f1LwWrXVKcOc-utdar3izgdsDtGLyh-j2pI3PP0K_D6wNbvcaV3VXhALLucHzAhCem_MLrPqUFKNxXeCycI8AWddBBJeyvemd1xXOFjUGRWFy3HRywTYdBi9PZY2XssKlbbkEZM5yDIZsR2Be1AXg-yOWOXyaoitABbtaI1fp47ZsrGP43NhGxvCbMtfYxU-AVdu6pCxc5k9Pt3qMjm5ky5-gUV7k5hnCmlPNiAYjKpI0teUUZ5orE4CS57Fk0kPvu_0VZVMvRDg_i8eiQYMANAiHBpF4aMtCoJ9pa327L4r5iWhFhwCLlQQ0M-DrZjTihkdRIrPYyDCUHAxsD72zABL2lcHWKtkmVgDDtraX2IQFktTev_XQ-mAmSBI1HO4gKFpJVonLc-eh1_2wfdLezstNsWjmJOC4B7GHnjaI7ZcUcc54kgKXfIDlwZqHI_nZqatzDmo4Bv0HfH3oYH_J179f6tr_l_EK3RkfTvbF_u507zm6S9zhjMEcWUejer4wL8DIrLOX7cnG6MdNC5M_tR6SDQ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtQwELZKkSouiH8CBYwE4gDRJrYTO0gIFcqqpbRCiEp7cx3boZWqJGyyWvXVeB_eg7Hz024R3Crtae3MjuPPM9-s7RmEXhQxifJCMwhLMhEyTUmYAc0OaaIzY4lIcl8zcv8g3Tlkn2fJbA39Gu7CuGOVg030htpU2v1HPgFqC84XyEoyKfpjEV-3p-_rn6GrIOV2WodyGh1E9uzZEsK35t3uNsz1S0Kmn75_3An7CgOhBibdhiYxhiplSWyzSNgkyiF8sIQVlPBE84zrhFOdpib221WJdmWeVMSKSGiSx5qC3GvoOqfAqmAt8dkY7MVcpGy4pCPSSQO-wu-YstA5YRbyFUfo6wX87RUuuMXLRzYv7dt6dzi9hW72PBZvdcC7jdZseQdt7Pc79XfR72-OjbtZx007pKPAam7xvAKsl_b0DOvxcoo1uK1wXflHQKyvJYJr1Z_5LtsG54sWg8uwJe5qumB3MQYvj1WLl6rBtSu-BGJOSgyUdhAwr9oKkP4WqxI-XfoVkIJ91pGL8nGfQNYrfGpdSWP4TVUa7HdSQFVXxKSu_B2gUW5zDx1eyYTfR-tlVdqHCBvBTEIM0CmqWOYSKxZGaBuBuxepSlSAXg_zK-suc4j0EZdIZYcGCWiQHg2SB-iDg8DY02X99l9U8x-yNyISuCuJWG4h6s0ZFVZQylWeWhXHSgDVDtArByDpXhlMrVb9FQtQ2GX5klswQJK5k7gB2lzpCTZFrzYPEJS9TWvk-QoM0POx2T3pzumVtlp0fTiE8FEaoAcdYschUSESwTPQUqxgeWXMqy3lybHPeA4OOQVPCHq9GWB_rte_X-qj_w_jGdoAEyK_7B7sPUY3iF-bKfCSTbTezhf2CbDNNn_qlzVGR1dtR_4Ah9uU1A |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Retention+strategies+are+routinely+communicated+to+potential+trial+participants+but+often+differ+from+what+was+planned+in+the+trial+protocol%3A+an+analysis+of+adult+participant+information+leaflets+and+their+corresponding+protocols&rft.jtitle=Trials&rft.au=Murphy%2C+Ellen&rft.au=Gillies%2C+Katie&rft.au=Shiely%2C+Frances&rft.date=2024-06-10&rft.eissn=1745-6215&rft.volume=25&rft.issue=1&rft.spage=372&rft_id=info:doi/10.1186%2Fs13063-024-08194-7&rft_id=info%3Apmid%2F38858790&rft.externalDocID=38858790 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1745-6215&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1745-6215&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1745-6215&client=summon |